In addition to representing a very useful model for the analysis of p-Tau localization, flow cytometry quantification of p-Tau can be employed to support the diagnosis of a proteinopathy, although not with the purpose of a differential diagnosis from other tauopathies, until a more detailed profile of p-Tau in different neurodegenerative diseases will be defined. This evidence concerns the gene MAPT and tauopathy.